BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 27756193)

  • 1. Evaluation of weight-based vancomycin dosing for hospitalized hemodialysis patients.
    Maxson R; Pate J; Starr J
    Ren Fail; 2016 Nov; 38(10):1677-1682. PubMed ID: 27756193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of a Weight Threshold-Based Vancomycin Dosing Protocol for Patients Undergoing Intermittent Hemodialysis.
    Sun LXL; Liu KD; Lynch S; Mistry M; Wise H; Iliescu E
    Can J Hosp Pharm; 2019; 72(5):369-376. PubMed ID: 31692636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vancomycin dosing and monitoring for patients with end-stage renal disease receiving intermittent hemodialysis.
    Crew P; Heintz SJ; Heintz BH
    Am J Health Syst Pharm; 2015 Nov; 72(21):1856-64. PubMed ID: 26490819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vancomycin dosing in patients on intermittent hemodialysis.
    Vandecasteele SJ; De Vriese AS
    Semin Dial; 2011; 24(1):50-5. PubMed ID: 21338394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial vancomycin dosing protocol to achieve therapeutic serum concentrations in patients undergoing hemodialysis.
    Zelenitsky SA; Ariano RE; McCrae ML; Vercaigne LM
    Clin Infect Dis; 2012 Aug; 55(4):527-33. PubMed ID: 22573855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Research of optimal dosing regimens and therapeutic drug monitoring for vancomycin by clinical pharmacists: analysis of 7-year data].
    Xu G; Chen E; Mao E; Che Z; He J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Jul; 30(7):640-645. PubMed ID: 30045790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aminoglycosides in intermittent hemodialysis: pharmacokinetics with individual dosing.
    Dager WE; King JH
    Ann Pharmacother; 2006 Jan; 40(1):9-14. PubMed ID: 16332944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of a divided-load intravenous vancomycin dosing strategy for critically ill patients.
    Denetclaw TH; Dowling TC; Steinke D
    Ann Pharmacother; 2013 Dec; 47(12):1611-7. PubMed ID: 24259632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving vancomycin prescription in critical illness through a drug use evaluation process: a weight-based dosing intervention study.
    Li J; Udy AA; Kirkpatrick CM; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2012 Jan; 39(1):69-72. PubMed ID: 22024354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allometric versus consensus guideline dosing in achieving target vancomycin trough concentrations.
    Brown ML; Hutchison AM; McAtee AM; Gaillard PR; Childress DT
    Am J Health Syst Pharm; 2017 Jul; 74(14):1067-1075. PubMed ID: 28522643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacokinetic/pharmacodynamic rationale for administering vancomycin via continuous infusion.
    Waineo MF; Kuhn TC; Brown DL
    J Clin Pharm Ther; 2015 Jun; 40(3):259-65. PubMed ID: 25865426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and Outcome of Pharmacy-Led Vancomycin Dosing and Monitoring.
    Momattin H; Zogheib M; Homoud A; Al-Tawfiq JA
    Chemotherapy; 2016; 61(1):3-7. PubMed ID: 26555724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vancomycin levels are frequently subtherapeutic during continuous venovenous hemodialysis (CVVHD).
    Wilson FP; Berns JS
    Clin Nephrol; 2012 Apr; 77(4):329-31. PubMed ID: 22445477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of an empiric vancomycin dosing algorithm for improved target concentration attainment in patients with thermal injury.
    Hill DM; Velamuri SR; Lanfranco J; Romero Legro I; Sinclair SE; Hickerson WL
    Burns; 2019 Mar; 45(2):423-432. PubMed ID: 30340863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a vancomycin dosing nomogram in achieving high target trough concentrations in Taiwanese patients.
    Leu WJ; Liu YC; Wang HW; Chien HY; Liu HP; Lin YM
    Int J Infect Dis; 2012 Nov; 16(11):e804-10. PubMed ID: 22917921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementation of a dose calculator for vancomycin to achieve target trough levels of 15-20 microg/mL in persons undergoing hemodialysis.
    Vandecasteele SJ; De Bacquer D; De Vriese AS
    Clin Infect Dis; 2011 Jul; 53(2):124-9. PubMed ID: 21690618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simple approach to improving vancomycin dosing in intensive care: a standardised loading dose results in earlier therapeutic levels.
    Truong J; Levkovich BJ; Padiglione AA
    Intern Med J; 2012 Jan; 42(1):23-9. PubMed ID: 22276559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a vancomycin dosing regimen for patients on high flux hemodialysis: an observational study.
    Soto Guerrero Y; Hernández Castillo R; Santiago E; Ramírez Yuch N; Jaume Anselmi F; Jové R; Flores R; Lebrón R; Ramírez Rivera J
    Bol Asoc Med P R; 2012; 104(3):10-4. PubMed ID: 23156886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of vancomycin dosing and subsequent serum concentrations in pediatric patients.
    Eiland LS; English TM; Eiland EH
    Ann Pharmacother; 2011 May; 45(5):582-9. PubMed ID: 21521865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a Pharmacist-Directed Vancomycin Dosing and Monitoring Pilot Program at a Tertiary Academic Medical Center.
    Marquis KA; DeGrado JR; Labonville S; Kubiak DW; Szumita PM
    Ann Pharmacother; 2015 Sep; 49(9):1009-14. PubMed ID: 25991831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.